Skip to main content

Day: March 17, 2021

DeepVerge PLC: Microtox® BT Evaluation of SARS-CoV-2 from breath test with Clinical Samples

YORK, United Kingdom, March 17, 2021 (GLOBE NEWSWIRE) — DeepVerge (LSE:DVRG.L), the environmental and life science AI company, announces initial data for ongoing Phase III clinical studies on the detection of SARS-CoV-2 on breath samples and identification of confirmed COVID19 positive patients .Since Q3 2020, DeepVerge scientists have been working under laboratory conditions with the Spike Protein (“S-Protein”) of SARS-CoV-2 on the SARS-CoV-2 virus inside the Containment Level 3 (“CL3”) laboratories at the University of Aberdeen.  In these studies, they have detected and identified the virus S-Protein in quantities at 40 femtogram[i] per millilitre (“Fg/mL”) at close to 100% sensitivity and specificity on DeepVerge’s Microtox® BT[ii] nano-optofluidic chip.In addition, under the clinical trial...

Continue reading

Gofore Plc: Gofore Plc has filed a listing application to transfer to the official list

GOFORE PLC STOCK EXCHANGE RELEASE 17 MARCH 2021 AT 17.45 EETGofore Plc has filed a listing application to transfer to the official listGofore Plc (“Gofore” or the “Company”) has today filed a listing application with Nasdaq Helsinki Ltd (the “Helsinki Stock Exchange”) to list the Company’s shares on the official list of the Helsinki Stock Exchange (the “Listing”). The Listing is conditional on the Helsinki Stock Exchange approving the Company’s listing application and the Finnish Financial Supervisory Authority approving the prospectus prepared in connection with the Listing. Trading in the Company’s shares is expected to commence on the official list of the Helsinki Stock Exchange on or about 23 March 2021.At the same time, the Company has requested its shares to be removed from the First North Growth Market Finland marketplace maintained...

Continue reading

Gofore Oyj: Gofore Oyj on jättänyt listalleottohakemuksen pörssilistalle siirtymiseksi

GOFORE OYJ PÖRSSITIEDOTE 17.3.2021 KLO 17.45Gofore Oyj on jättänyt listalleottohakemuksen pörssilistalle siirtymiseksiGofore Oyj (”Gofore” tai ”Yhtiö”) on tänään jättänyt listalleottohakemuksen Nasdaq Helsinki Oy:lle (”Helsingin Pörssi”) Yhtiön osakkeiden ottamiseksi kaupankäynnin kohteeksi Helsingin Pörssin pörssilistalle (”Listautuminen”). Listautuminen on ehdollinen sille, että Helsingin Pörssi hyväksyy listalleottohakemuksen ja että Finanssivalvonta hyväksyy Listautumisen yhteydessä laaditun listalleottoesitteen. Kaupankäynnin Yhtiön osakkeilla odotetaan alkavan Helsingin Pörssin pörssilistalla arviolta 23.3.2021.Suunnitellun Listautumisen tavoitteena on Goforen tunnettavuuden kasvattaminen ja likviditeetin parantaminen sekä laajemman omistajapohjan saavuttaminen.”Olemme kehittyneet sekä yhtiönä että yhteisönä viime vuodet huimaa tahtia....

Continue reading

ARHT Announces Closing of Previously Announced Public Offering Raising Gross Proceeds of $7.9 million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, March 17, 2021 (GLOBE NEWSWIRE) — ARHT Media Inc. (TSX VENTURE: ART) (“ARHT” or the “Company“) is pleased to announce that it has closed its previously announced overnight marketed offering (the “Offering”) of units of the Company (the “Units”) at a price of $0.24 per Unit (the “Offering Price”) for aggregate gross proceeds of $7,980,400.08. The Offering was led by Leede Jones Gable Inc.Each Unit consists of one common share in the capital of the Company (each a “Common Share”) and one common share purchase warrant (each, a “Warrant”). Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of $0.33 for a period of 36 months following the closing of the Offering; provided,...

Continue reading

Mitesco Expands Executive Team, Adds Philip Keller as Chief Financial Officer

MINNEAPOLIS, MN, March 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Mitesco, Inc. (OTCQB: MITI) today announced the appointment of Mr. Phillip Keller as its Chief Financial Officer (CFO).“Phillip Keller is an excellent addition to our executive team, with over 30 years experience in finance and accounting, including both private and public companies, and numerous M&A transactions,” noted Larry Diamond, CEO. He continued, “Our plans for expansion and uplisting to a major exchange will be challenging and we believe Phillip brings the relevant healthcare and finance experience to complement the existing team. Further, he has significant international experience which may prove valuable to our longer-term plans.”“I am excited to join the Mitesco Team,” says Keller. “Mitesco and its operating companies, The Good...

Continue reading

Treasury Bond Auction Announcement – RIKB 23 0515 – RIKS 33 0321

On the Auction Date, between 10:30 am and 11:00 am, the Government Debt Management will auction Treasury bonds in the Series, with the ISIN numbers and with the Maturity Dates according to the table above. Payments for the Treasury bonds must be received by the Central Bank before 14:00 on the Settlement Date, and the Bonds will be delivered in electronic form on the same day. Article 6 of the General Terms of Auction for Treasury bonds applies for the right to purchase an additional 10%.Further reference is made to the description of the Treasury bond and the General Terms of Auction for Treasury bonds on the Government Debt Management website.For additional information please contact Oddgeir Gunnarsson, Government Debt Management, at +354 569 9635.

Continue reading

Tilkynning um útboð ríkisbréfa – RIKB 23 0515 – RIKS 33 0321

Á útboðsdegi, milli kl. 10:30 og 11:00, fer fram útboð hjá Lánamálum ríkisins á ríkisbréfum í þeim flokkum, með þeim ISIN númerum og með þeim gjalddögum sem fram koma í töflunni hér að ofan. Greiðslur fyrir ríkisbréfin þurfa að berast Seðlabankanum fyrir kl. 14:00 á uppgjörsdegi og verða bréfin afhent rafrænt sama dag. Um 10% viðbótarkaupréttinn gildir 6. gr. í almennum útboðsskilmálum ríkisbréfa.Að öðru leyti er vísað til lýsingar skuldabréfaflokksins og almennra útboðsskilmála ríkisbréfa á heimasíðu Lánamála ríkisins.Nánari upplýsingar veitir Oddgeir Gunnarsson, Lánamálum ríkisins í síma 569 9635.

Continue reading

Pinehurst Capital II Announces Proposed Changes in Accordance with New CPC Policy

TORONTO, March 17, 2021 (GLOBE NEWSWIRE) — Pinehurst Capital II Inc. (TSXV: PINH.P) (the “Corporation“), a capital pool company listed on the TSX Venture Exchange (“TSXV“), announces that pursuant to recent changes by the TSXV to its Capital Pool Company program and the TSXV’s Policy 2.4 – Capital Pool Companies (“Policy 2.4“), which became effective as at January 1, 2021 (the “New CPC Policy“), the Corporation intends to seek approval to implement certain amendments to further align with the New CPC Policy.Pursuant to the New CPC Policy, in order for the Corporation to align certain of its policies with the New CPC Policy, it is required to obtain the approval of disinterested shareholders of the Corporation. At a special meeting of the shareholders of the Corporation held on...

Continue reading

Offentliggørelse af fusionsdokumenter for forventet afdelingsfusion i Investeringsforeningen Sparinvest

Bestyrelsen for Investeringsforeningen Sparinvest har på bestyrelsesmøde den 17. marts 2021 truffet beslutning om at fusionere følgende afdelinger med tilhørende andelsklasserVirksomhedsobligationer Nye Markeder KL og Nye Obligationsmarkeder KLOvennævnte afdelingsfusion omfatter følgende afdelinger, som er optaget til handel på Nasdaq Copenhagen A/S:Nye Obligationsmarkeder KL som den fortsættende afdelingVirksomhedsobligationer Nye Markeder KL som den ophørende afdelingFor den fortsættende afdeling kan bestyrelsen i henhold til lov om investeringsforeninger m.v. træffe beslutning om fusionen. Beslutningen er truffet under forudsætning af, at fusionen vedtages af investorerne i den ophørende afdeling på den ordinære generalforsamling den 14. april 2021.Det forventes, at fusionen gennemføres som en skattepligtig fusion, og at ombytningen...

Continue reading

VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce Stroke in At-Risk Patients in Analyses of Landmark REDUCE-IT® Study Presented at International Stroke Conference 2021

28% and 32% significant reductions in first and total strokes, respectively, demonstrated with VASCEPA compared to placebo, as well as reductions in first and total ischemic strokes each by 36%, without increasing hemorrhagic stroke, in statin-treated patients with elevated cardiovascular riskConsistent reductions in overall stroke and in ischemic stroke observed across multiple subgroupsAdministration of pure icosapent ethyl, VASCEPA, represents a novel clinical approach to stroke reductionREDUCE-IT® STROKE abstract receives prestigious Paul Dudley White International Scholar Award to recognize the authors with the highest ranked abstract from the United States at the International Stroke Conference 2021DUBLIN, Ireland and BRIDGEWATER, N.J., March 17, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.